Pharmaceutical companies could serve their own interests by supporting research on the efficacy of psychotherapy on premature ejaculation

International Journal of Impotence Research

Volumn 20, Issue 2, 2008, Pages 115-120

  Rowland, D ^a   Cooper, S ^a   MacIas, L ^a  

^a VALPARAISO UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CARDIOVASCULAR DISEASE; COGNITIVE THERAPY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG INDUSTRY; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL INFORMATION; MEDICAL RESEARCH; OBESITY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PREMATURE EJACULATION; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SEXUAL DYSFUNCTION; TREATMENT OUTCOME;

DRUG INDUSTRY; EJACULATION; EVIDENCE-BASED MEDICINE; HUMANS; MALE; PSYCHOTHERAPY; RESEARCH; RESEARCH SUPPORT AS TOPIC; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 40649116480     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901559     Document Type: Review

References (31)

1. Masters WH, Johnson VE. Human Sexual Inadequacy. Little, Brown & Co: Boston, 1970.
2. Kaplan HS. The New Sex Therapy. Brunner/Mazel: New York, 1974.
3. Heiman JR, Meston C. Empirically validated treatment for sexual dysfunction. Annu Rev Sex Res 1997; 8: 148-194.
4. Rowland DL, Cooper SE, Slob AK. The treatment of premature ejaculation: psychological and biological strategies. Drugs Today 1998; 34: 879-899.
5. DeAmicis LA, Goldberg DC, LoPiccolo J, Friedman J, Davies L. Clinical follow-up of couples treated for sexual dysfunction. Arch Sex Behav 1985; 14: 467-489.
6. Heiman JR, LoPiccolo J. Clinical outcome of sex therapy. Arch Gen Psychiatry 1983; 40: 443-449.
7. Hawton K, Catalan J, Martin P, Fagg J. Long-term outcome of sex therapy. Behav Res Ther 1986; 24: 665-675.
8. Hawton K. Sex therapy research: Has it withered on the vine? Annu Rev Sex Res 1992; 3: 49-72.
9. Schover LR, Leiblum SR. Commentary: the stagnation of sex therapy. J Psychol Hum Sex 1994; 6: 5-30.
10. Perelman MA. A new combination treatment for premature ejaculation: a sex therapist's perspective. J Sex Med 2006. doi: 10.1111/j.1743-6109.2006. 00238.x.
11. American Psychological Association. American Psychological Association statement policy on evidence-based practice in psychology. Retrieved 1 September, 2005 from http://www.apa.org/practice/ebpreport.pdf.
12. McMahon CG, Abdo C, Incrocci L, Perelman M, Rowland D, Waldinger M et al. Disorders of orgasm and ejaculation in men. J Sex Med 2004; 1: 58-65.
13. Waldinger M. The neurobiological approach to premature ejaculation. J Urol 2002; 168: 2359-2367.
14. Althof SE. Therapeutic weaving: the integration of treatment techniques. In: Levine SB, Risen CB, Althof SE, (eds). Handbook of Clinical Sexuality for Mental Health Professionals. Brunner-Routledge: New York, 2003, pp 359-376.
15. Barada JH. Optimizing outcomes of oral therapy for patients with erectile dysfunction. Rev Urol 2003; 5: S28-S34.
16. Althof SE. Sexual therapy in the age of pharmacotherapy. Annu Rev Sex Res 2006; 17: 116-131.
17. Rowland DL, Cooper SE. Behavioral and psychological models in ejaculatory function research. Curr Sex Health Rep 2005; 2: 29-34.
18. Althof SE. Psychological treatment strategies for rapid ejaculation: rationale, practical aspects, and outcome. World J Urol 2005; 23: 89-92.
19. American Psychological Association. Empirically supported therapy relationships: conclusions and recommendations of the division 29 task force. Psychotherapy: Theory Res Pract Train 2001; 38: 495-497.
20. Straub RL. Health Psychology 2nd edn. Worth Publishers: New York, 2007, pp 375-383.
21. Rowland DL, Tai WL, Slob AK. Predicting responsiveness to the treatment of rapid ejaculation with 25mg clomipramine as needed. Int J Impot Res 2004; 16: 354-357.
22. Norcross JC (ed). Psychotherapy Relationships That Work: Therapist Contributions and Their Responsiveness to Patient Needs. Oxford University Press: New York, 2002, pp 3-16.
23. Kazdin AE. Treatment outcomes, common factors, and continued neglect of mechanisms of change. Clin Psychol Sci Prac 2005; 12: 184-188.
24. Nathan PE, Gorman JM. A Guide to Treatments that Work 2nd edn. Oxford University Press: New York, 2002, pp 497-525.
25. Wampold BE, Bhati KS. Attending to the omissions: a historical examination of evidence-based practice movements. Prof Psychol Res Prac 2004; 35: 563-570.
26. Bohart AC, Tallman K. How Clients make Therapy Work: The Process of Active Self-Healing. American Psychological Association: Washington, DC, 1999.
27. Pfizer. Pfizer: Who we are: Public policy. Retrieved 2 January, 2006 from http://www.pfizer.com/pfizer/are/about_public/ mn_about_clemente_article_medicare.jsp.
28. Miller KL. The Pill Machine. Newsweek (Atlantic Edn); 2001; 138: 44.
29. West D. Doing well by doing good. Pharmaceut Exec 2000; 20: 98.
30. Poor market. rich rewards. Economist 2004; 372: 65-66.
31. GlaxoSmithKline. GlaxoSmithKline: About GSK: The Company: The Spirit of GSK. Retrieved 2 January, 2006 from http://gsk.co.nz/about.asp?pageID=466.